FDA Reorganization Will Not Include John Taylor, Hamburg’s Great Actor
This article was originally published in The Pink Sheet Daily
Executive Summary
Taylor’s exit from the agency comes as commissioner awaits recommendations from a panel of senior agency officials on how to ensure the centers support Office of Regulatory Affairs’ activities without duplication.
You may also be interested in...
FDA Mines Small Field Of Industry Candidates To Fill Executive Vacancies
Criteria for FDA’s leadership posts are extensive and the hiring process is long, but Richard Moscicki still believes industry and academics should consider applying. As more long-time officials retire, he says it is critical to fill open positions to allow for a “smooth transition over an extended period of time.”
FDA Mines Small Field Of Industry Candidates To Fill Executive Vacancies
Criteria for FDA’s leadership posts are extensive and the hiring process is long, but Richard Moscicki still believes industry and academics should consider applying. As more long-time officials retire, he says it is critical to fill open positions to allow for a “smooth transition over an extended period of time.”
FDA Searches Small Industry Candidate Pool To Fill Executive Vacancies
Criteria for FDA’s leadership vacancies are extensive and the hiring process is long, but Richard Moscicki still believes industry and academics should consider applying for the openings.